First line of the email MUST contain NCT # and Site #.
CONTACT
Lead
Bristol-Myers Squibb
Age
5–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants must have been diagnosed with Juvenile Psoriatic Arthritis (JPsA).
Participants must have at least three joints that are affected by arthritis.
Participants must have tried at least one type of medicine for JPsA for at least three months, but it didn't work well or caused problems.
You may not be if
Participants must not have been diagnosed with JPsA before 5 years of age.
Participants must not have other types of Juvenile Idiopathic Arthritis (JIA) that aren't JPsA,
Participants must not have a history of chronic eye inflammation (uveitis), or were diagnosed with uveitis within the last three months.
Clareo Health | A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
